Chih‐Yen Tu

4.3k total citations
164 papers, 2.8k citations indexed

About

Chih‐Yen Tu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Chih‐Yen Tu has authored 164 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Pulmonary and Respiratory Medicine, 38 papers in Oncology and 34 papers in Epidemiology. Recurrent topics in Chih‐Yen Tu's work include Lung Cancer Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (29 papers) and Pleural and Pulmonary Diseases (28 papers). Chih‐Yen Tu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (29 papers) and Pleural and Pulmonary Diseases (28 papers). Chih‐Yen Tu collaborates with scholars based in Taiwan, United States and China. Chih‐Yen Tu's co-authors include Chia‐Hung Chen, Te‐Chun Hsia, Wu-Huei Hsu, Chuen-Ming Shih, Hung‐Jen Chen, Wei‐Chih Liao, Te‐Chun Shen, Cheng‐Li Lin, Te‐Chun Hsia and Wei‐Chien Huang and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Cancer Cell.

In The Last Decade

Chih‐Yen Tu

158 papers receiving 2.7k citations

Peers

Countries citing papers authored by Chih‐Yen Tu

Since Specialization

Citations

This map shows the geographic impact of Chih‐Yen Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Yen Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Yen Tu more than expected).

Fields of papers citing papers by Chih‐Yen Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Yen Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Yen Tu. The network helps show where Chih‐Yen Tu may publish in the future.

Co-authorship network of co-authors of Chih‐Yen Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Yen Tu. A scholar is included among the top collaborators of Chih‐Yen Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Yen Tu. Chih‐Yen Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection 2025 ·Journal of Microbiology Immunology and Infection ·Yuchang Fu, (unknown), Yuhua Su, Yu-Chao Lin, Chih‐Yen Tu, (unknown), Po‐Ren Hsueh	1
2	Reduced mortality with antimicrobial stewardship guided by BioFire FilmArray Blood Culture Identification 2 panel in critically ill patients with bloodstream infection: A retrospective propensity score-matched study 2024 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), Wei-Cheng Chen, (unknown), Shinn‐Jye Liang, Chih‐Yen Tu, Yu-Chao Lin, Po‐Ren Hsueh	4
3	The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study 2024 ·BMC Cancer ·(unknown), Chi‐Chen Lin, Wei‐Chih Liao, Yu-Chao Lin, Chia‐Hung Chen, (unknown), Chih‐Yen Tu, Te‐Chun Hsia	3
4	Optimal first-line treatment for EGFR-mutated NSCLC: a comparative analysis of osimertinib and second-generation EGFR-TKIs 2024 ·BMC Pulmonary Medicine ·(unknown), Chia‐Hung Chen, Wei‐Chih Liao, Yu-Chao Lin, (unknown), Te‐Chun Hsia, (unknown), Chih‐Yen Tu	3
5	Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer 2024 ·Advanced Science ·Yu‐Chuan Lin, Mei‐Chih Chen, Shi‐Wei Huang, Yeh Chen, Jennifer Hui‐Chun Ho, Fang‐Yu Lin, (unknown), Hung‐Che Chiang, (unknown), Chih‐Yen Tu, Der‐Yang Cho, Shao‐Chih Chiu	11
6	Biomechanical Analysis of Rectus Femoris Kinesio Taping Effects on Post-Muscle Fatigue Stop-Jump Task Performance 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), Chih‐Yen Tu, Chenfu Huang, Hsien‐Te Peng	1
7	Stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical early‐stage non‐small‐cell lung cancer: a population‐based study 2024 ·Thoracic Cancer ·(unknown), (unknown), Chih‐Yen Tu, Te‐Chun Hsia, (unknown), Hsin‐Yuan Fang, (unknown), Chun‐Ru Chien	1
8	Highly Mimetic Ex Vivo Lung‐Cancer Spheroid‐Based Physiological Model for Clinical Precision Therapeutics 2023 ·Advanced Science ·Ming‐You Shie, Hsin‐Yuan Fang, (unknown), Chia‐Che Ho, Chih‐Yen Tu, Pei‐Chih Lee, Po‐Ren Hsueh, Chia‐Hung Chen, (unknown), (unknown), (unknown), Yucheng Shen, Jan‐Gowth Chang, (unknown), (unknown), Ben Wang, Mien‐Chie Hung, Der‐Yang Cho, Yi‐Wen Chen	13
9	Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort 2023 ·Open Medicine ·(unknown), Te‐Chun Shen, Cheng‐Li Lin, Chih‐Yen Tu, Te‐Chun Hsia, (unknown)	1
10	P12‐5: Correlation between bispectral index (BIS) and modified observer's assessment of alertness/sedation (MOAA/S) score in flexible bronchoscopy 2021 ·Respirology ·Chia‐Hung Chen, Chih‐Yen Tu, Wei‐Chih Liao, (unknown), (unknown), (unknown), Wei‐Chun Chen, Te‐Chun Hsia, Wu‐Huei Hsu	0
11	A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 2021 ·International Journal of COPD ·Wei‐Chun Huang, Chih‐Yu Chen, Wei‐Chih Liao, (unknown), Wei‐Chun Chen, Chih‐Yen Tu, Chia‐Hung Chen, (unknown)	4
12	l‐lactic acidosis confers insensitivity to PKC inhibitors by competing for uptake via monocarboxylate transporters 2021 ·Journal of Cellular Physiology ·(unknown), (unknown), (unknown), Fang‐Ju Cheng, Yi‐Cheng Shen, Chao‐Jung Chen, (unknown), Chih‐Hsin Tang, Wei‐Chien Huang, Chia‐Hung Chen, Chih‐Yen Tu	1
13	When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment 2020 ·International Journal of COPD ·(unknown), (unknown), Wei‐Chih Liao, (unknown), Wei‐Chun Chen, Te‐Chun Hsia, Chih‐Yen Tu, Chia‐Hung Chen, Wu‐Huei Hsu	4
14	Risk of pleural empyema in patients with schizophrenia: a nationwide propensity-matched cohort study in Taiwan 2018 ·BMJ Open ·Te‐Chun Shen, Chia‐Hung Chen, (unknown), Cheng‐Li Lin, Ting‐Chang Chang, Chih‐Yen Tu, Te‐Chun Hsia, Chuen-Ming Shih, Wu-Huei Hsu, Fung-Chang Sung	7
15	Periodontal Treatment Reduces Risk of Adverse Respiratory Events in Patients With Chronic Obstructive Pulmonary Disease 2016 ·Medicine ·Te‐Chun Shen, Pei‐Ying Chang, Cheng‐Li Lin, Chia‐Hung Chen, Chih‐Yen Tu, Te‐Chun Hsia, Chuen‐Ming Shih, Wu‐Huei Hsu, Fung‐Chang Sung, Chia‐Hung Kao	32
16	Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan 2015 ·Journal of the Formosan Medical Association ·(unknown), Chia‐Hung Chen, Te‐Chun Shen, (unknown), (unknown), (unknown), Chih‐Yi Chen, Te‐Chun Hsia, Wei‐Chih Liao, Chih‐Yen Tu, Chuen-Ming Shih, Wu-Huei Hsu	32
17	Diagnostic Pitfalls of Discriminating Lymphoma-Associated Effusions 2015 ·Medicine ·Hung‐Jen Chen, Kuo‐Yang Huang, Guan-Chin Tseng, (unknown), Li-Yuan Bai, Shinn‐Jye Liang, Chih‐Yen Tu, Richard W. Light	3
18	Improved diagnostic yield of bronchoscopy in peripheral pulmonary lesions: combination of radial probe endobronchial ultrasound and rapid on-site evaluation. 2015 ·PubMed Central ·Chia‐Hung Chen, (unknown), (unknown), (unknown), Wei Chun Chen, Te Chun Hsia, (unknown), Chih‐Yen Tu, (unknown), (unknown), Ko Pen Wang	51
19	Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells 2013 ·Molecular Pharmacology ·Te‐Chun Hsia, Chih‐Yen Tu, Yun‐Ju Chen, Ya-Ling Wei, (unknown), (unknown), (unknown), (unknown), Ming‐Hsin Yeh, Chia-Jui Yen, Yung‐Luen Yu, Tzung-Chi Huang, Chih‐Yang Huang, Mien‐Chie Hung, Wei‐Chien Huang	34
20	Thoracic endometriosis 2011 ·Canadian Medical Association Journal ·Yao‐Tsung Lin, Chih‐Yen Tu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact